Cystic fibrosis affects mostly Caucasians. And that, suspects John Strouse, a Johns Hopkins hematologist who has compared data about the two diseases, is one reason why funding for cystic fibrosis research, drug development, and patient advocacy dwarfs that for sickle-cell disease. In 2011, the most recent year for which his data is available, spending on cystic fibrosis totaled $254 million—nearly four times the $66 million that was spent on sickle cell, even though the latter affects three times as many people. #blackfacts #whitepeoplebelike #cysticfibrosis #cysticfibrosisawareness #cysticfibrosisproblems











